BrainStorm Cell Therapeutics
BCLI
#10072
Rank
A$15.4 M
Marketcap
$2.70
Share price
-3.89%
Change (1 day)
-61.93%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2024 (TTM): -A$14.84 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$37.91 Million, an increase over its 2021 earnings that were of -A$38.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$14.84 Million
2022 -A$37.91 Million-0.74%
2021 -A$38.19 Million-23.12%
2020 -A$49.68 Million36.8%
2019 -A$36.31 Million66.71%
2018 -A$21.78 Million181.66%
2017 -A$7.74 Million-0.6%
2016 -A$7.78 Million-41.31%
2015 -A$13.26 Million-8.22%
2014 -A$14.45 Million89.74%
2013 -A$7.62 Million42.27%
2012 -A$5.35 Million-12.45%
2011 -A$6.12 Million63.04%
2010 -A$3.75 Million35.52%
2009 -A$2.77 Million-48.99%
2008 -A$5.43 Million-44.39%
2007 -A$9.75 Million
2005 -A$5.05 Million-91.44%
2004 -A$59 Million94007.62%
2003 -A$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.27 B-1,882.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.91 Billion 5,736.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.24 Billion 7,905.02%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.97 B-19,399.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.15 Billion 840.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.4 Billion 2,486.97%๐Ÿ‡บ๐Ÿ‡ธ USA